By how many mmHg does midodrine typically raise systolic blood pressure?

Blood Pressure Increase with Midodrine

Midodrine typically increases standing systolic blood pressure by approximately 15-30 mmHg, with the most consistent effect being around 20-22 mmHg at 1 hour post-dose when using the standard 10 mg dose.

Dose-Response Relationship

The magnitude of blood pressure elevation depends significantly on the dose administered:

• 10 mg dose: Increases standing systolic BP by approximately 20-22 mmHg at 1 hour post-dose 1, 2
• 20 mg dose: Produces increases of about 30 mmHg at 1 hour, with effects sustained for up to 4 hours 1
• Lower doses (2.5-5 mg): Produce smaller, less clinically significant increases 2

The FDA label data demonstrates that 10 mg and 20 mg doses produced standing 1-minute systolic pressure increases of approximately 30 mmHg at 1 hour in dose-response trials 1. However, the 20 mg dose carries substantially higher risk, with supine systolic pressure ≥200 mmHg occurring in 45% of patients versus 22% with 10 mg 1.

Clinical Context and Timing

Peak effect occurs 1-2 hours after administration, corresponding to peak blood concentrations of the active metabolite desglymidodrine 1. The effect partially sustains:

• At 2 hours post-dose: approximately 12-15 mmHg elevation persists
• At 3 hours post-dose: effect diminishes but remains present with 10 mg dosing
• Duration extends to 4 hours with 20 mg dosing 1

Evidence Quality Considerations

The European Society of Cardiology guidelines note that midodrine "increases BP in both supine and upright posture" in patients with orthostatic hypotension, though they acknowledge it's not a cure and doesn't help all patients 3. The guideline cites three randomized placebo-controlled trials supporting its use at 5-20 mg three times daily 3.

Important caveat: A 2013 systematic review and meta-analysis found "insufficient and low quality evidence" for midodrine in orthostatic hypotension, with the mean change in systolic BP compared to placebo being only 4.9 mmHg (not statistically significant, p=0.65) 4. However, the change in standing systolic BP before and after giving midodrine was 21.5 mmHg (p<0.001) 4, consistent with other studies.

Supine vs. Standing Pressures

Critical distinction: Midodrine raises both supine and standing pressures:

• Supine systolic: increases by 16 mmHg on average
• Sitting systolic: increases by 20 mmHg on average
• Standing systolic: increases by 20-30 mmHg depending on dose 1

This creates the primary safety concern—supine hypertension occurs in approximately 13.4% of patients on 10 mg, with systolic pressures reaching 200 mmHg 1. Patients with baseline supine systolic BP >180 mmHg should not receive midodrine 1.

Practical Dosing Algorithm

Start with 10 mg three times daily (last dose no later than 6 PM to avoid nocturnal supine hypertension) 3, 1. This produces the optimal balance of efficacy (20-22 mmHg increase) versus safety risk. Lower starting doses of 2.5-5 mg may be considered in elderly or frail patients, but clinical trials show these produce minimal benefit 2.

Monitor supine and sitting blood pressures closely throughout treatment, as uncontrolled hypertension increases stroke risk 1.